Dimensional Fund Advisors
CHRS icon

Dimensional Fund Advisors’s Coherus Oncology CHRS Stock Holding History

Dimensional Fund Advisors’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$18.2K Sell
15,055
-20,342
-57% -$27.8K ﹤0.01% 3219
2026
Q2 		$49.6K Hold
35,397
– – ﹤0.01% 3191
2026
Q1 		$59.8K Buy
+35,397
New +$62.9K ﹤0.01% 3164

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

Dimensional Fund Advisors's CHRS Position: Q3 2026 in Review

Dimensional Fund Advisors reduced its Coherus Oncology (CHRS) stake by 57% in Q3 2026, selling an estimated $27.8K and leaving 15,055 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3219.

Dimensional Fund Advisors first reported a position in CHRS in Q1 2026 and has held it in 3 quarters since. The position peaked at $59.8K in Q1 2026. 59 funds tracked by Wall St. Rank hold CHRS as of Q3 2026.

  • Dimensional Fund Advisors held 15,055 shares of Coherus Oncology worth $18.2K as of Q3 2026.
  • Dimensional Fund Advisors sold 20,342 Coherus Oncology shares in Q3 2026, an estimated $27.8K.
  • Coherus Oncology made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #3219 holding.
  • Dimensional Fund Advisors first reported a position in Coherus Oncology in Q1 2026 and has held it in 3 quarters since.
  • Dimensional Fund Advisors's Coherus Oncology position peaked at $59.8K in Q1 2026.
  • 59 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.